<DOC>
	<DOCNO>NCT01810952</DOCNO>
	<brief_summary>The investigator hypothesize include patient weight glucocorticoid dose use safely initiate insulin treatment diabetic/hyperglycemic patient treat pharmacological dos glucocorticoid .</brief_summary>
	<brief_title>The Management Glucocorticoid-Induced Hyperglycemia Hospitalized Patients</brief_title>
	<detailed_description>The target fast serum glucose ( FSG ) pre-meal SG 90-140 mg/dL , random SG le 180 mg/dL , take consideration ADA/AACE target glucose level non-ICU patient ( 15 ) . The Glargine/Lispro Protocol include 0.2 unit/kg/day insulin glargine daily dose 40-80 unit , twice daily dose less 40 80 unit ; plus 0.2 unit/kg/day lispro divide three meal insulin-naïve patient . A `` coverage '' dose 0.1 unit/kg/day lispro 10 mg prednisone equivalent divide 3 meal . The maximum start `` coverage '' dose 0.4 units/kg per day . The prandial dose lispro increase 10 % pre-lunch , pre-dinner , bedtime SG 141-200 mg/dL , 20 % pre-lunch , pre-dinner bedtime SG &gt; 200 mg/dL . The prandial dose lispro decrease 10 % pre-lunch , pre-dinner , bedtime SG 70-89 mg/dL , 20 % pre-lunch , pre-dinner bedtime SG le 70 mg/dL . The Glargine/Lispro/NPH Protocol include 0.2 unit/kg/day insulin glargine per G/L ; plus 0.2 unit/kg/day lispro divide three meal insulin-naïve patient . A `` coverage '' dose 0.1 unit/kg/day Neutral Protamine Hagedorn ( NPH ) 10 mg prednisone equivalent give twice daily administration glucocorticoid . The maximum start `` coverage '' dose 0.4 units/kg per day . The NPH dose increase 10 % pre-lunch , pre-dinner , bedtime SG 141-200 mg/dL , 20 % pre-lunch , pre-dinner bedtime SG great 200 mg/dL . The NPH dose decrease 10 % pre-lunch , pre-dinner , bedtime SG 70-89 mg/dL , 20 % pre-lunch , pre-dinner bedtime SG le 70 mg/dL . In protocols glargine dose increase 10 % fast glucose value 141-200 mg/dL 20 % fast glucose value 200 mg/dL , decrease 10 % FSG 70-89 mg/dL 20 % FSG le 70 mg/dL . If patient outpatient regimen include total daily dose insulin ( TDI ) exceed 0.4 unit/kg/day , TDI continue 50 % give glargine daily dose 40-80 unit , twice daily dose less 40 80 unit ; 50 % give lispro divide three meal . The patient still randomly assign either one two protocol describe previously . If patient TDI le 0.4 unit/kg/day addition oral antidiabetic medication outpatient , oral antidiabetic medication discontinue patient start 0.5 unit/kg/day divide 50 % glargine give daily dose 40-80 unit , twice daily dose less 40 80 unit ; 50 % lispro divide three meal . The patient randomly assign either one two protocol base upon even odd hospital number .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Admission Chronic Obstructive Pulmonary Disease ( COPD ) exacerbation . Treatment pharmacological dos glucocorticoid ( GCs ) ≥10 mg prednisone equivalent maintenance dose GCs outpatient setting . Treatment pharmacological dos GCs ≥10 mg prednisone equivalent maintenance dose GCs outpatient setting . Have either previous diagnosis diabetes mellitus treat diet medication , hemoglobin A1c ≥6.5 % , confirm inpatient hyperglycemia define fast laboratory glucose finger stick read ≥126 mg/dL random glucose reading ≥200 mg/dL two determination . Unwilling sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>glucocorticoid</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>diabetes mellitus</keyword>
</DOC>